D Dimer Testing Market

D-dimer Testing Market

  • HC-1428
  • 4.5 Rating
  • 160 Pages
  • Upcoming
  • 72 Reviews
  • PDF Excel PPT
raksha

Author:

Raksha Sharma

Vineet

Fact-checked by:

Vineet Pandey

Shreyas

Editor:

Shreyas Tandon

The global D-dimer testing market size was USD 1.30 Bn in 2022 and is likely to reach USD 1.85 Bn by 2031, expanding at a CAGR of 4.60% during 2023–2031. The market growth is attributed to the rising demand for advanced point-of-care testing, and increased incidence rate of respiratory and cardiovascular diseases.

D-dimer, also known as fibrin degradation fragment, is a protein fragment that occurs in the bloodstream when fibrinolysis takes place for the breakdown of a blood clot formed when injured.

Global D Dimer Testing Market Outlook

During the process of fibrinolysis, the clumps present in the blood get broken down; after completion of degradation, the number of clots remains in the blood known as D-dimers. Medical professionals used to carry out elevated d dimer testing by extracting blood samples by using needles to take specimens for further examination to identify the existence of serious blood clots.

D-dimer test is performed when symptoms of blood clotting disorder occurred such as leg pain & swelling, shortness of breathing, nasal congestion, chest pain, and rise in heartbeat, this test is used for diagnosis of various thrombotic disorders such as deep vein thrombosis (DVT) in which clot floats in a deep vein of lower legs followed by other organs of the body.

Pulmonary embolism (PE) is occurred due to obstruction of arteries in the respiratory system and disseminated intravascular coagulation (DIC). As a result, some severe conditions involve the formation of blood clots to a large extent, which can cause organ failure and stroke, due to the obstruction of blood flow to the central nervous system.

The test utilizes monoclonal antibodies of latex particles incorporated in elevated D dimer that increase the molecular weight of the immunocomplexes of the test specimen. The changes observed in the turbidity of the specimen are examined by photometrical analyzers and turbidimetric analyzers.

The market report finds that the COVID-19 pandemic has positively impacted the growth of the global market. The outbreak of the COVID-19 pandemic is creating opportunities for the expansion of the D-dimers market, due to the rising demand of advance diagnostic tools and testing kits.

D Dimer Testing Market Dynamics

The global D-dimer testing market report has up-to-date insights that help in formulating a strategic roadmap about the estimated market scenario and performance during 2023 to 2031.

D-dimer Testing Market Dynamic

Drivers

The increasing prevalence of pathophysiological conditions such as various cardiovascular disorders, acute pulmonary syndromes, arterial or venous thromboembolism, cardiac arrhythmias, and acute pancreatitis is a key driver for the rising demand for testing. Moreover, rising demand for advanced point-of-care testing due to lessening the time of treatment and reducing the time of patient stay in the hospital is projected to propel the market growth in the upcoming years. The rising number of geriatric populations who are exposed to severe health risks is expected to boost the market.

Restraints

The presence of heterophilic antibodies prevents the accurate test results of D-dimer testing in the clinical intervention of cardiovascular and pulmonary diseases. This is projected to hinder the market growth in the upcoming years.

Opportunities

The development of aptamers, peptides that bind to a target receptor, lessens the use of antibodies in elevated D dimer testing. These aptamers are offering a higher shelf life of monoclonal antibodies, which can offer profitable opportunities for the market growth.

Scope of D Dimer Testing Market Report

The global D-dimer testing market research report includes an assessment of the market trends, market segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

D-dimer Testing Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2020–2021

Forecast Period

2023–2031

Segmentation

Product (Analyzers and Reagents & Consumables), Test Type (Clinical Laboratory Tests and Point-of-care Tests), Testing Method (Enzyme-linked Immunosorbent Assays, Latex-enhanced Immunoturbidimetric Assays, Fluorescence Immunoassays, and Others), Application (Deep Vein Thrombosis, Pulmonary Embolism, Disseminated Intravascular Coagulation, and Others), and End-user (Hospitals, Academic & Research Institutes, Diagnostic Centers, and Others),

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, D Dimer Testing Market Size and Analysis, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast

Key Players Covered in the Report

F. Hoffmann-La Roche Ltd; Abbott.; Siemens Healthcare GmbH; Bio-Rad Laboratories, Inc.; Laboratory Corporation of America® Holdings.; ARUP Laboratories.; Diazyme Laboratories, Inc.; BIOMÉRIEUX; Sekisui Diagnostics; BioMedica Diagnostics; BD.; Helena Laboratories; and Quidel Corporation.

D Dimer Testing Market Segment Insights

Based on product, the D-dimer testing market is bifurcated into analyzers and reagents & consumables. The reagents & consumables segment is expected to expand at a significant growth rate during the projection period. The increased selling of reagents and testing kits, the wide accessibility of extemporaneous reagents, and the emergence of highly sophisticated robotic D-dimer assay are the key factors that are expected to expand the segment during the forecast period.

The analyzers segment is anticipated to expand at a rapid pace during the forecast period, owing to a reduction in laboratory time along with increasing clinical research that is expected to augmentation of market growth.

On the basis of test type, the market is classified into clinical laboratory tests and point-of-care tests. The clinical laboratory tests segment is anticipated to constitute a dominant share of the market in the coming years, due to the emergence of highly sophisticated D-dimer assays employed for the diagnosis of disseminated intravascular coagulation.

The point-of-care tests segment is estimated to exhibit robust growth during the forecast period, owing to the introduction of various automated methods. The growth of the segment is attributed to excellent design, improved patient care, lesser maintenance charges, reduced risk of errors, and lesser time of diagnosis. The constant efforts of Research & development to develop fast pace point-of-care tests are estimated to boost the segment growth.

Based on testing method, the D-dimer testing market is classified into enzyme-linked immunosorbent assay (ELISA), latex-enhanced immunoturbidimetric assays, fluorescence immunoassays, and others. The ELISA segment is expected to register a robust growth rate during the forecast period, owing to its high sensitivity towards coagulation biological factors. The emerging automated ELISA assays such as the VIDAS method are expected to propel the segment growth.

The fluorescence immunoassay segment is anticipated to register a high CAGR during the forecast period, due to the rising demand for automated fluorescence immunoassay methods for D-dimer testing. These assays provide accurate results due to their higher sensitivity and employed affordable reagents.

On the basis of application, the market is divided into deep vein thrombosis (DVT), pulmonary embolism (PE), disseminated intravascular coagulation (DIC), and others. The deep vein thrombosis segment is expected to register a robust CAGR during the forecast period, due to the increasing incidence of deep vein thrombosis with the risk of complications such as difficulty in diagnosis and hindered movement of hospitalized patients. Patients undergone various surgeries are at higher risk of deep vein thrombosis, which simultaneously increases admittance to hospitals and drug treatment. These are the key factors that propel the segment’s growth in the upcoming years.

D-dimer Testing Market Application

Based on end-user, the D-dimer testing market is segmented into hospitals, academic & research institutes, diagnostic centers, and others. The hospital’s segment is accounted for a dominant market share, due to the increasing hospital admittance rate of patients along with enhancement in pulmonary embolism cases across the globe.

The diagnostic center’s segment is expected to register vigorous CAGR during the forecast period, due to low-cost diagnosis and treatment provided by diagnostic centers with enhancement in patient satisfaction.

In terms of region, the global D-dimer testing market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period, due to wide clinical applications of blood clotting testing stimulated by regulatory bodies that involve in the management of coagulation testing.

The Asia Pacific is expected to grow at a rapid pace during the forecast period, owing to government initiatives for awareness of coagulation tests. These initiatives help medical professionals, which ultimately causes an increased demand for d-dimer tests in the region.

D-dimer Testing Market Region

Segments

The global D-dimer testing market has been segmented on the basis of

Products

  • Analyzers
  • Reagents & Consumables

Test Types

  • Clinical Laboratory Tests
  • Point-of-care Tests

Testing Methods

  • Enzyme-linked Immunosorbent Assays
  • Latex-enhanced Immunoturbidimetric Assays
  • Fluorescence Immunoassays
  • Others

Applications

  • Deep Vein Thrombosis
  • Pulmonary Embolism
  • Disseminated Intravascular Coagulation
  • Others

End-users

  • Hospitals
  • Academic & Research Institutes
  • Diagnostic Centers
  • Others

Region

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • F. Hoffmann-La Roche Ltd
  • Abbott.
  • Siemens Healthcare GmbH
  • Bio-Rad Laboratories, Inc.
  • Laboratory Corporation of America® Holdings.
  • ARUP Laboratories.
  • Diazyme Laboratories, Inc.
  • BIOMÉRIEUX
  • Sekisui Diagnostics
  • BioMedica Diagnostics
  • BD.
  • Helena Laboratories
  • Quidel Corporation.

Competitive Landscape

Key players competing in the global D-dimer testing market are F. Hoffmann-La Roche Ltd; Abbott.; Siemens Healthcare GmbH; Bio-Rad Laboratories, Inc.; Laboratory Corporation of America® Holdings.; ARUP Laboratories.; Diazyme Laboratories, Inc.; BIOMÉRIEUX; Sekisui Diagnostics; BioMedica Diagnostics; BD.; Helena Laboratories; and Quidel Corporation.

These companies adopted development strategies including mergers, acquisitions, partnerships, collaboration, product launches, and production expansion to expand their consumer base worldwide.

  • In April 2019, Diazyme Laboratories introduced its D-dimer assay technique to expand its testing operation.

Global D Dimer Testing Market Key Players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. D-dimer Testing Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. D-dimer Testing Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. D-dimer Testing Market - Supply Chain
  4.5. Global D-dimer Testing Market Forecast
     4.5.1. D-dimer Testing Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. D-dimer Testing Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. D-dimer Testing Market Absolute $ Opportunity
5. Global D-dimer Testing Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. D-dimer Testing Market Size and Volume Forecast by Applications
     5.3.1. Deep Vein Thrombosis
     5.3.2. Pulmonary Embolism
     5.3.3. Disseminated Intravascular Coagulation
     5.3.4. Others
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global D-dimer Testing Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. D-dimer Testing Market Size and Volume Forecast by End Users
     6.3.1. Hospitals
     6.3.2. Academic & Research Institutes
     6.3.3. Diagnostic Centers
     6.3.4. Others
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global D-dimer Testing Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. D-dimer Testing Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global D-dimer Testing Demand Share Forecast, 2019-2026
8. North America D-dimer Testing Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America D-dimer Testing Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America D-dimer Testing Market Size and Volume Forecast by Applications
     8.4.1. Deep Vein Thrombosis
     8.4.2. Pulmonary Embolism
     8.4.3. Disseminated Intravascular Coagulation
     8.4.4. Others
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. North America D-dimer Testing Market Size and Volume Forecast by End Users
     8.7.1. Hospitals
     8.7.2. Academic & Research Institutes
     8.7.3. Diagnostic Centers
     8.7.4. Others
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America D-dimer Testing Demand Share Forecast, 2019-2026
9. Latin America D-dimer Testing Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America D-dimer Testing Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America D-dimer Testing Market Size and Volume Forecast by Applications
     9.4.1. Deep Vein Thrombosis
     9.4.2. Pulmonary Embolism
     9.4.3. Disseminated Intravascular Coagulation
     9.4.4. Others
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Latin America D-dimer Testing Market Size and Volume Forecast by End Users
     9.7.1. Hospitals
     9.7.2. Academic & Research Institutes
     9.7.3. Diagnostic Centers
     9.7.4. Others
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America D-dimer Testing Demand Share Forecast, 2019-2026
10. Europe D-dimer Testing Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe D-dimer Testing Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe D-dimer Testing Market Size and Volume Forecast by Applications
     10.4.1. Deep Vein Thrombosis
     10.4.2. Pulmonary Embolism
     10.4.3. Disseminated Intravascular Coagulation
     10.4.4. Others
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Europe D-dimer Testing Market Size and Volume Forecast by End Users
     10.7.1. Hospitals
     10.7.2. Academic & Research Institutes
     10.7.3. Diagnostic Centers
     10.7.4. Others
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe D-dimer Testing Demand Share Forecast, 2019-2026
11. Asia Pacific D-dimer Testing Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific D-dimer Testing Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific D-dimer Testing Market Size and Volume Forecast by Applications
     11.4.1. Deep Vein Thrombosis
     11.4.2. Pulmonary Embolism
     11.4.3. Disseminated Intravascular Coagulation
     11.4.4. Others
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Asia Pacific D-dimer Testing Market Size and Volume Forecast by End Users
     11.7.1. Hospitals
     11.7.2. Academic & Research Institutes
     11.7.3. Diagnostic Centers
     11.7.4. Others
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific D-dimer Testing Demand Share Forecast, 2019-2026
12. Middle East & Africa D-dimer Testing Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa D-dimer Testing Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa D-dimer Testing Market Size and Volume Forecast by Applications
     12.4.1. Deep Vein Thrombosis
     12.4.2. Pulmonary Embolism
     12.4.3. Disseminated Intravascular Coagulation
     12.4.4. Others
  12.5. Basis Point Share (BPS) Analysis by Applications
  12.6. Y-o-Y Growth Projections by Applications
  12.7. Middle East & Africa D-dimer Testing Market Size and Volume Forecast by End Users
     12.7.1. Hospitals
     12.7.2. Academic & Research Institutes
     12.7.3. Diagnostic Centers
     12.7.4. Others
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa D-dimer Testing Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global D-dimer Testing Market: Market Share Analysis
  13.2. D-dimer Testing Distributors and Customers
  13.3. D-dimer Testing Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. F. Hoffmann-La Roche Ltd
     13.4.2. Abbott.
     13.4.3. Siemens Healthcare GmbH
     13.4.4. Bio-Rad Laboratories, Inc.
     13.4.5. Laboratory Corporation of America® Holdings.
     13.4.6. ARUP Laboratories.
     13.4.7. Diazyme Laboratories, Inc.
     13.4.8. BIOMÉRIEUX
     13.4.9. Sekisui Diagnostics
     13.4.10. BioMedica Diagnostics
     13.4.11. BD.
     13.4.12. Helena Laboratories
     13.4.13. Quidel Corporation.

Purchase Premium Report

FAQ Section

Some frequently asked quetions about this report!

The global D-dimer testing market size was valued at around USD 1.30 billion in 2022 and is likely to reach USD 1.85 billion by 2031.

The global D-dimer testing market is estimated to register a compound annual growth rate (CAGR) of around 4.60% during the forecast period.

For region analysis, North America dominates the global D-dimer testing market during the forecast period.

Some of the key global D-dimer testing market players are F. Hoffmann-La Roche Ltd; Abbott.; Siemens Healthcare GmbH; Bio-Rad Laboratories, Inc.; Laboratory Corporation of America® Holdings.; ARUP Laboratories.; Diazyme Laboratories, Inc.; BIOMÉRIEUX; Sekisui Diagnostics; BioMedica Diagnostics; BD.; Helena Laboratories; and Quidel Corporation.